Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
The sudden pandemic of SARS-Cov-2 (also known as novel coronavirus disease 2019, COVID-19) poses a severe threat to hundreds of millions of lives in the world. The complete cure of the virus largely relies on the immune system, which becomes particularly a challenge for the cancer subjects, whose im...
Main Authors: | Shuang Dong, Chenggang Luo, Xuebo Hu, Jing Zhang, Qian Cai, Yu Qian, Fengming Ran, Wuling Ou, Jun Wang, Qing Huang, Tianhua Ren, Guang Han, Feng Zhang, Wei Wei, Xinjun Liang, Huiting Xu, Sheng Wang, Lulu Shi, Shaozhong Wei, Sheng Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01555/full |
Similar Items
-
Interim Guideline for Treatment Options on Cancer Patients During SARS-CoV-2 Pandemic
by: LUO Chenggang, et al.
Published: (2020-04-01) -
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
by: Jing Zhang, et al.
Published: (2020-10-01) -
Cardiotoxicity and Mechanisms of Immune Checkpoint Inhibitors
by: DONG Shuang, et al.
Published: (2018-11-01) -
Clinicopathologic Characteristics and Prognosis of Colon Cancer Patients with Different Primary Locations
by: XU Hongli, et al.
Published: (2018-09-01) -
A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer
by: Ping Lu, et al.
Published: (2021-03-01)